(Q48559768)

12 February 2018

title

Psychiatric symptoms associated with L-asparaginase administration (English)

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

31 January 2023

author name string

J. Holland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4531491

31 January 2023

S. Fasanello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4531491

31 January 2023

T. Onuma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4531491

31 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4531491

31 January 2023

publication date

1 May 1974

1 reference

12 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0022395674900302?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

https://api.elsevier.com/content/article/PII:0022395674900302?httpAccept=text/plain

31 January 2023

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

Journal of Psychiatric Research

31 January 2023

published in

1 reference

12 February 2018

volume

10

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

105-113

1 reference

12 February 2018

TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children

31 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors

31 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

31 January 2023

L-asparaginase

7

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease

31 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

Toxicity of E. coli L-asparaginase in man

31 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity

31 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

Nature and extent of the biochemical lesion in human epileptogenic cerebral cortex; an approach to its control in vitro and in vivo.

31 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

Delirium, a syndrome of cerebral insufficiency

31 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

Delirium, clouding of consciousness and confusion

31 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0022-3956(74)90030-2

31 January 2023

Identifiers

1 reference

12 February 2018

1 reference

12 February 2018